Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis C virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019;4(6):477-487
El-Sayed MH, Razavi H. Global estimate of HCV infection in the pediatric and adolescent population. J Hepatol 2015; 62 (suppl 2): 831-32 (abstr).
Satsangi S, Chawla Y K. Viral hepatitis: Indian scenario. Med J Armed Forces India. 2016; 72(3): 204-210.
Sood A, Suryaprasad A, Trickey A, et al. The burden of hepatitis C virus infection in Punjab, India: A population-based serosurvey. PLoS One. 2018;13(7):e0200461.
Indolfi G, Hierro L, Dezsofi A, et al. Treatment of Chronic Hepatitis C Virus Infection in Children: A Position Paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. JPGN 2018; 66: 505-515
Ghany MG, Marks KM, Morgan TR, et al. Hepatitis C Guidance 2019 Update: AASLDIDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2019 Dec. [Epub ahead of print]
Jonas MM, Romero R, Sokal EM, et al. Safety and efficacy of sofosbuvir/velpatasvir in pediatric patients 6 to <18 years old with chronic hepatitis C infection [abstract 748]. The Liver Meeting. 2019.
Jonas MM, Lon HK, Rhee S, et al. Pharmacokinetics of glecaprevir/pibrentasvir in children with chronic HCV infection: interim analysis of part 2 of the DORA study [abstract 1551]. The Liver Meeting. Boston. 2019.